Kitov Pharma Ltd’s $35 Million Registered Direct Offering


Fischer Behar Chen Well Orion & Co advised Kitov Pharma Ltd. on the deal.

Kitov Pharma Ltd. executed a US$35 million registered direct offering of shares represented by American Depositary Shares (ADSs) and warrants to purchase ADSs.

Kitov Pharma Ltd. operates as a pharmaceutical company and discovers and develops medicines, drugs, and other pharmaceutical products for the treatment of osteoarthritis pain and hypertension.

H.C. Wainwright & Co., LLC acted as exclusive placement agent for the offering.

The FBC & Co team was led by Raz Tepper (Picture) Sharon Rosen.

Involved fees earner: Sharon Rosen – Fischer Behar Chen Well Orion & Co; Raz Tepper – Fischer Behar Chen Well Orion & Co;

Law Firms: Fischer Behar Chen Well Orion & Co;

Clients: Kitov Pharmaceuticals Holdings;

Author: Michael Patrini.